KRON – kronos bio, inc. (US:NASDAQ)
Stock Stats
News
Kronos Bio Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024 [Yahoo! Finance]
Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024
Kronos Bio, Inc. (NASDAQ: KRON) was downgraded by analysts at TD Cowen from a "buy" rating to a "hold" rating.
Kronos Bio, Inc. (NASDAQ: KRON) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $1.00 price target on the stock, down previously from $6.00.
Form EFFECT Kronos Bio, Inc.
Form SC 13G/A Kronos Bio, Inc. Filed by: Omega Fund V, L.P.
Form 10-Q Kronos Bio, Inc. For: Sep 30
Form 8-K Kronos Bio, Inc. For: Nov 13
Form 8-K Kronos Bio, Inc. For: Nov 04
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.